UT Medical Center

News

UT Medical Researcher’s Grant Sets Longevity Records

University of Tennessee Graduate School of Medicine researcher, Alan Solomon, M.D., professor of medicine and director of the Human Immunology and Cancer/Alzheimer’s Disease and Amyloid-Related Disorders Research Program, was awarded a five-year renewal on a grant from the National Institutes of Health’s (NIH) National Cancer Institute that now is one of the longest active NIH grants in NIH history and is the longest running NIH grant in UT history.

The grant, originally awarded to Dr. Solomon in 1965, has been renewed continually for the past 42 years and has provided more than $12 million to fund Dr. Solomon’s work at UT.

“The length of the NIH grant and the total amount of money associated with it reflect strong support of the preeminent research program at the UT Graduate School of Medicine, an undertaking that has gained national and international attention,” said James J. Neutens, PhD, Dean, UT Graduate School of Medicine.
Dr. Solomon has devoted these 42 years to the study, diagnosis and treatment of cancer and for the past 10 years on amyloidosis, a protein-folding disorder associated with rheumatoid arthritis, Alzheimer’s disease, adult-onset (type-2) diabetes and an illness related to multiple myeloma called primary or AL amyloidosis.

“I am very appreciative and grateful for the initial and the continuing NIH grant, which will make it possible for us to achieve our ultimate goal to improve the outcome of patients with these medically devastating amyloid-associated diseases,” Dr. Solomon said. “I am thankful to receive this award particularly because so few NIH research grants are being funded at this time due to imposed limitations in governmental support for medical research.”

In 1992, Dr. Solomon, who received his M.D. degree from Duke University, was named one of the American Cancer Society Clinical Research Professors and is Scientific Advisor to the International Myeloma Foundation and the Amyloidosis Research Foundation. He has published more than 250 articles in scientific and medical journals on his research.